IRIS (Intelligent Retinal Imaging Systems) and Biomedix Sign Strategic Partnership Agreement

Expands Biomedix Population Health Management Solution Today IRIS and Biomedix announced the signing of a strategic partnership agreement that expands the Biomedix Xchange Population Health Management Solution to include the testing, diagnosis and care planning for diabetic retinopathy examinations. “For value-based care organizations, the early identification of diabetic retinopathy through Read more…

Upcoming Webinar: Advancing Healthcare Equity By Addressing the Amputation Epidemic

A major consequence of racism in healthcare is the increased rate of adverse outcomes of chronic conditions in minority populations. Non-traumatic lower-extremity amputations are just one of the major adverse outcomes more likely to happen to patients in under-served communities. These amputations carry high risks of mortality, related complications, and Read more…

O'Brien ETF 128 being used on a patient to identify peripheral neuropathy

Biomedix to offer a free O’Brien ETF128 tuning fork with PADnet purchases for Diabetes Awareness Month

In honor of Diabetes Awareness Month this November, Biomedix is inviting all healthcare professionals to optimize care for their diabetic patients through the earlier identification of related chronic complications such as Peripheral Artery Disease (PAD), and now Peripheral Neuropathy through a new partnership with O’Brien Medical. To build on our Read more…

Drug Test